Sergey Brin Funds Psychedelic Research for Mental Health Treatment

CosmicTaco · 2024-07-21T12:26:37.888368+05:30

- Google co-founder Sergey Brin is funding the development of a hallucinogen derived from a rainforest shrub for mental health treatment. - Brin's non-profit, Catalyst4, is covering $15mn of a $25mn funding round for psychedelic start-up Soneira, which is researching ibogaine for traumatic brain injury (TBI). - Ibogaine, historically used in spiritual rituals, has shown promise in improving mental health symptoms and cognitive function in military veterans with TBI. - Soneira is also developing a synthetic version of ibogaine and combining it with heart medications to reduce the risk of fatal cardiac arrhythmia. - The interest from Brin's vehicle highlights Silicon Valley's growing enthusiasm for psychedelics, with nearly $180mn invested in psychedelic biotechs this year. Source: Financial Times

Google co-founder Sergey Brin is funding the development of a hallucinogen derived from a rainforest shrub for mental health treatment.
Brin's non-profit, Catalyst4, is covering $15mn of a $25mn funding round for psychedelic start-up Soneira, which is researching ibogaine for traumatic brain injury (TBI).
Ibogaine, historically used in spiritual rituals, has shown promise in improving mental health symptoms and cognitive function in military veterans with TBI.
Soneira is also developing a synthetic version of ibogaine and combining it with heart medications to reduce the risk of fatal cardiac arrhythmia.
The interest from Brin's vehicle highlights Silicon Valley's growing enthusiasm for psychedelics, with nearly $180mn invested in psychedelic biotechs this year.

Source: Financial Times